Alambic Investment Management’s AbbVie ABBV Stock Holding History

Alambic Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,567	Closed	-$1.41M	–	456
2017 Q4	$1.41M	Sell	14,567 -20,370	-58%	-$1.92M	0.17%	207
2017 Q3	$3.1M	Sell	34,937 -700	-2%	-$53.3K	0.34%	102
2017 Q2	$2.58M	Sell	35,637 -7,950	-18%	-$534K	0.31%	89
2017 Q1	$2.84M	Buy	43,587 +14,625	+50%	+$919K	0.35%	68
2016 Q4	$1.81M	Buy	28,962 +3,352	+13%	+$205K	0.32%	94
2016 Q3	$1.61M	Sell	25,610 -290	-1%	-$18.8K	0.38%	74
2016 Q2	$1.6M	Buy	25,900 +16,790	+184%	+$1.02M	0.4%	60
2016 Q1	$520K	Buy	+9,110	New	+$508K	0.17%	208

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Alambic Investment Management's ABBV Position: Q1 2018 in Review

Alambic Investment Management sold out of AbbVie (ABBV) in Q1 2018, closing a stake of 14,567 shares — an estimated $1.41M sold.

Alambic Investment Management first reported a position in ABBV in Q1 2016 and held it in 8 quarters. The position peaked at $3.1M in Q3 2017. 2,015 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

Alambic Investment Management reported no remaining AbbVie position as of Q1 2018 after selling out during the quarter.
Alambic Investment Management sold 14,567 AbbVie shares in Q1 2018, an estimated $1.41M.
Alambic Investment Management first reported a position in AbbVie in Q1 2016 and held it in 8 quarters.
Alambic Investment Management's AbbVie position peaked at $3.1M in Q3 2017.
2,015 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Alambic Investment Management's 13F filing for Q1 2018, filed 8 May 2018.